CUE - Cue Biopharma, Inc.
0.751
-0.029 -3.822%
Share volume: 159,045
Last Updated: 05-12-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.78
-0.03
-0.04%
Summary score
30%
Profitability
25%
Dept financing
7%
Liquidity
50%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-32.36%
Return on assets
-23.71%
Return on sales
0%
Return on invested capital
317.37%
Total debt ratio
22.26%
Debt ratio change over timeo
0%
Current Ratio
7.41%
Quick Ratio
0%
Cash Position Ratio
5.8%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-21.01%
Return on assets
-15.13%
Return on sales
0%
Return on invested capital
378.93%
Total debt ratio
27.58%
Debt ratio change over timeo
0%
Current Ratio
4.65%
Quick Ratio
0%
Cash Position Ratio
3.19%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-13.52%
Return on assets
-10.8%
Return on sales
0%
Return on invested capital
581.79%
Total debt ratio
20.92%
Debt ratio change over time
0%
Current Ratio
5.94%
Quick Ratio
0%
Cash Position Ratio
4.02%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CUE | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -32.36% | 17.45% | 4.69% | 19.89% |
| Return on assets | -23.71% | 3.37% | 3.35% | 11.41% |
| Return on sales | 0% | 23.96% | 25.96% | 42.05% |
| Return on invested capital | 317.37% | 5.2% | 4.37% | -272.99% |
| Profitability | 25% | 44% | 29% | 75% |
| Total debt ratio | 22.26% | 77% | 57.66% | 53.92% |
| Debt ratio change over time | 0% | 0% | 10.55% | 0% |
| Dept financing | 7% | 25% | 44% | 18% |
| Current Ratio | 4.65% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 3.19% | 0.17% | 0.53% | 0.31% |
| Liquididy | 50% | 25% | 33% | 21% |
| Short-term ratios | CUE | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -21.01% | 44.06% | 6.24% | 17.3% |
| Return on assets | -15.13% | 3.88% | 3.22% | 9.33% |
| Return on sales | 0% | 27.04% | 24.93% | 40.02% |
| Return on invested capital | 378.93% | 9.69% | 4.96% | -224.06% |
| Profitability | 25% | 53% | 28% | 60% |
| Total debt ratio | 27.58% | 91.8% | 61.39% | 55.88% |
| Debt ratio change over time | 0% | 0% | 12.93% | 0% |
| Dept financing | 8% | 25% | 42% | 15% |
| Current Ratio | 4.65% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 3.19% | 0.17% | 0.53% | 0.31% |
| Liquididy | 50% | 30% | 36% | 27% |
